Literature DB >> 12413604

Phage display technology: clinical applications and recent innovations.

Hassan M E Azzazy1, W Edward Highsmith.   

Abstract

Phage display is a molecular diversity technology that allows the presentation of large peptide and protein libraries on the surface of filamentous phage. Phage display libraries permit the selection of peptides and proteins, including antibodies, with high affinity and specificity for almost any target. A crucial advantage of this technology is the direct link that exists between the experimental phenotype and its encapsulated genotype, which allows the evolution of the selected binders into optimized molecules. Phage display facilitates engineering of antibodies with regard to their size, valency, affinity, and effector functions. The selection of antibodies and peptides from libraries displayed on the surface of filamentous phage has proven significant for routine isolation of peptides and antibodies for diagnostic and therapeutic applications. This review serves as an introduction to phage display, antibody engineering, the development of phage-displayed peptides and antibody fragments into viable diagnostic reagents, and recent trends in display technology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413604     DOI: 10.1016/s0009-9120(02)00343-0

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  60 in total

1.  In vitro evolution and affinity-maturation with Coliphage qβ display.

Authors:  Claudia Skamel; Stephen G Aller; Alain Bopda Waffo
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant protein.

Authors:  R Arjen Kramer; Freek Cox; Marieke van der Horst; Sonja van der Oudenrijn; Pieter C M Res; Judith Bia; Ton Logtenberg; John de Kruif
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

3.  Identification of novel specific allosteric modulators of the glycine receptor using phage display.

Authors:  Megan E Tipps; Jessica E Lawshe; Andrew D Ellington; S John Mihic
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

4.  Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin B.

Authors:  Pawan Kumar Singh; Ranu Agrawal; Dev Vrat Kamboj; Garima Gupta; M Boopathi; Ajay Kumar Goel; Lokendra Singh
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

5.  Screening phage display libraries for organ-specific vascular immunotargeting in vivo.

Authors:  Philippe Valadon; Jeff D Garnett; Jacqueline E Testa; Marc Bauerle; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

Review 6.  Employing phage display to study the mode of action of Bacillus thuringiensis Cry toxins.

Authors:  Luisa Elena Fernández; Isabel Gómez; Sabino Pacheco; Iván Arenas; Sarjeet S Gilla; Alejandra Bravo; Mario Soberón
Journal:  Peptides       Date:  2007-12-14       Impact factor: 3.750

7.  Identification of binding peptides of the ADAM15 disintegrin domain using phage display.

Authors:  Jing Wu; Min-Chen Wu; Lian-Fen Zhang; Jian-Yong Lei; Lei Feng; Jian Jin
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

8.  Phage display for identification of serum biomarkers of traumatic brain injury.

Authors:  Sarbani Ghoshal; Vimala Bondada; Kathryn E Saatman; Rodney P Guttmann; James W Geddes
Journal:  J Neurosci Methods       Date:  2016-05-07       Impact factor: 2.390

Review 9.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

Review 10.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.